C4 Therapeutics, Inc.C4 Therapeutics, Inc.C4 Therapeutics, Inc.

C4 Therapeutics, Inc.

No trades
See on Supercharts

CCCC fundamentals

An in-depth look to C4 Therapeutics, Inc. operating, investing, and financing activities

CCCC free cash flow for Q3 24 is -24.12 M USD. For 2023, CCCC free cash flow was -108.55 M USD and operating cash flow was -106.84 M USD.

Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth